These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program. Sader HS; Castanheira M; Mendes RE; Toleman M; Walsh TR; Jones RN Int J Antimicrob Agents; 2005 Jan; 25(1):57-61. PubMed ID: 15620827 [TBL] [Abstract][Full Text] [Related]
4. Novel variant (bla(VIM-11)) of the metallo-{beta}-lactamase bla(VIM) family in a GES-1 extended-spectrum-{beta}-lactamase-producing Pseudomonas aeruginosa clinical isolate in Argentina. Pasteran F; Faccone D; Petroni A; Rapoport M; Galas M; Vázquez M; Procopio A Antimicrob Agents Chemother; 2005 Jan; 49(1):474-5. PubMed ID: 15616342 [No Abstract] [Full Text] [Related]
6. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea. Cho HH; Kwon GC; Kim S; Koo SH J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063 [TBL] [Abstract][Full Text] [Related]
7. A highly carbapenem-resistant Pseudomonas aeruginosa isolate with a novel blaVIM-4/blaP1b integron overexpresses two efflux pumps and lacks OprD. Maniati M; Ikonomidis A; Mantzana P; Daponte A; Maniatis AN; Pournaras S J Antimicrob Chemother; 2007 Jul; 60(1):132-5. PubMed ID: 17483142 [TBL] [Abstract][Full Text] [Related]
8. Metallo-beta-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in Brazil. Viana Vieira V; Lourenço da Fonseca E; Paulo Vincente AC Clin Microbiol Infect; 2005 Nov; 11(11):937. PubMed ID: 16216114 [No Abstract] [Full Text] [Related]
9. First report of the carbapenem-resistant Pseudomonas aeruginosa producing IMP-7 metallo-beta-lactamase in Slovakia. Ohlasova D; Kmet V; Niks M Int J Antimicrob Agents; 2007 Oct; 30(4):370-1. PubMed ID: 17709230 [No Abstract] [Full Text] [Related]
10. Evaluation of phenotypic tests for the detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa in a low prevalence country. Samuelsen O; Buarø L; Giske CG; Simonsen GS; Aasnaes B; Sundsfjord A J Antimicrob Chemother; 2008 Apr; 61(4):827-30. PubMed ID: 18227087 [TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology of carbapenem-resistant Pseudomonas aeruginosa carrying metallo-beta-lactamase genes in Taiwan. Huang YT; Chang SC; Lauderdale TL; Yang AJ; Wang JT Diagn Microbiol Infect Dis; 2007 Oct; 59(2):211-6. PubMed ID: 17521840 [TBL] [Abstract][Full Text] [Related]
12. Identification of Pseudomonas aeruginosa clinical strains harboring the bla(VIM-2) metallo-beta-lactamase gene in Akita Prefecture, Japan. Yatsuyanagi J; Saito S; Ito Y; Ohta K; Kato J; Harata S; Suzuki N; Amano K Jpn J Infect Dis; 2004 Jun; 57(3):130-2. PubMed ID: 15218228 [No Abstract] [Full Text] [Related]
14. Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase. Gales AC; Menezes LC; Silbert S; Sader HS J Antimicrob Chemother; 2003 Oct; 52(4):699-702. PubMed ID: 12951331 [TBL] [Abstract][Full Text] [Related]
15. [Susceptibility to chemotherapeutics and the occurrence of metallo-beta-lactamases in hospital Pseudomonas aeruginosa strains]. Nowak P; Targosz A; Budak A; Oleksiak D; Geza G; Skałkowska M Med Dosw Mikrobiol; 2006; 58(3):231-7. PubMed ID: 17340998 [TBL] [Abstract][Full Text] [Related]
16. Prevalence and characterization of metallo-beta-lactamases in clinical isolates of pseudomonas aeruginosa. Luzzaro F; Endimiani A; Docquier JD; Mugnaioli C; Bonsignori M; Amicosante G; Rossolini GM; Toniolo A Diagn Microbiol Infect Dis; 2004 Feb; 48(2):131-5. PubMed ID: 14972383 [TBL] [Abstract][Full Text] [Related]
17. Detection of metallo-beta-lactamase-producing Pseudomonas aeruginosa strains isolated from burn patients in Ahwaz, Iran. Khosravi AD; Mihani F Diagn Microbiol Infect Dis; 2008 Jan; 60(1):125-8. PubMed ID: 17900848 [TBL] [Abstract][Full Text] [Related]
18. Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy. Wolter DJ; Acquazzino D; Goering RV; Sammut P; Khalaf N; Hanson ND Clin Infect Dis; 2008 Jun; 46(12):e137-41. PubMed ID: 18462098 [TBL] [Abstract][Full Text] [Related]
19. Carbapenem-hydrolysing beta-lactamase from clinical isolates of Pseudomonas aeruginosa in Portugal. Cardoso O; Sousa JC; Leitão R; Peixe L J Antimicrob Chemother; 1999 Jul; 44(1):135. PubMed ID: 10459824 [No Abstract] [Full Text] [Related]
20. Resistance to carbapenems among Pseudomonas aeruginosa isolated from patients of transplant wards. Mlynarczyk G; Sawicka-Grzelak A; Szymanek K; Buczkowska T; Pazik J; Durlik M; Pacholczyk M; Lagiewska B; Chmura A; Paczek L; Mlynarczyk A Transplant Proc; 2009 Oct; 41(8):3258-60. PubMed ID: 19857725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]